| Home > Documents in Process > Regional disparities of antidementia drug treatment in Germany: what can we learn for the new generation of Alzheimer's therapies. > Access to Fulltext |
| Restricted | |||||||
DZNE-2025-01365
|
|||||||
| version 1 |
| ||||||